Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients

被引:27
作者
Wang, Lin [1 ,2 ]
Cao, Xi [1 ,2 ]
Wang, Zhenzi [1 ,2 ]
Gao, Yuhua [1 ,2 ]
Deng, Juan [1 ,2 ]
Liu, Xueen [1 ,2 ]
Zhuang, Hui [1 ,2 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Microbiol, Beijing, Peoples R China
[2] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Ctr Infect Dis, Beijing, Peoples R China
关键词
chronic hepatitis B; covalently closed circular DNA; HBV RNA; hepatitis B core-related antigen; nucleos(t) ide analogues; CORE-RELATED ANTIGEN; HBV DNA; HEPATOCELLULAR-CARCINOMA; CCCDNA; REACTIVATION; ASSOCIATION; INFECTION; PREDICTOR; CESSATION; THERAPY;
D O I
10.1128/JCM.01303-18
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The purpose of this study was to explore the correlations of serum hepatitis B core-related antigen (HBcrAg) with intrahepatic Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) and HBV total DNA in hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) patients. Serum HBcrAg and other parameters, including HBV DNA, HBV RNA, HBeAg, hepatitis B surface antigen (HBsAg), hepatitis B core antibody (anti-HBc), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were quantitatively measured at baseline and follow-up time points. Intrahepatic HBV cccDNA and total DNA were quantitatively detected at baseline and 96 weeks. Grading of liver necroinflammation and staging of hepatic fibrosis were assessed at baseline and 96 weeks. Correlations between serum HBcrAg and other parameters were analyzed by Pearson's correlation analysis. The results showed that pretreatment HBcrAg correlated significantly with HBV total DNA levels (r = 0.328, P = 0.003) in 82 CHB patients, and, after removing three outliers, with intrahepatic HBV cccDNA (r = 0.323, P = 0.004; n = 79). Serum HBcrAg correlated better with HBV cccDNA in patients with lower levels of serum HBV DNA (stratified by 7 log IU/ml of HBV DNA; r = 0.656, P = 0.003 versus r = -0.02, P = 0.866). Significant inverse correlations were found between HBcrAg and grade of liver necroinflammation (r = -0.245, P = 0.037), stage of hepatic fibrosis (r = -0.360, P = 0.002) at baseline. Serum HBcrAg presented significant correlation with intrahepatic HBV cccDNA in patients with HBeAg seroconversion at 96 weeks (r = 0.622, P = 0.006). The decrease in HBcrAg showed significant correlation with the decrease in HBV cccDNA after 96-week NA therapy (r = 0.282, P = 0.043). Serum HBcrAg also correlated significantly with other serum markers at baseline and 96 weeks of NA therapy. In conclusion, baseline HBcrAg and its decreased value were significantly correlated with the corresponding intrahepatic HBV cccDNA.
引用
收藏
页数:9
相关论文
共 29 条
  • [1] Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy
    Bourne, E. J.
    Dienstag, J. L.
    Lopez, V. A.
    Sander, T. J.
    Longlet, J. M.
    Hall, J. G.
    Kwiatkowski, R. W.
    Wright, T.
    Lai, C. L.
    Condreay, L. D.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2007, 14 (01) : 55 - 63
  • [2] Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B
    Chen, En-Qiang
    Feng, Shu
    Wang, Meng-Lan
    Liang, Ling-Bo
    Zhou, Ling-Yun
    Du, Ling-Yao
    Yan, Li-Bo
    Tao, Chuan-Min
    Tang, Hong
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [3] Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese Medical Association., 2010, GUOJI LIUXINGBINGXUE, V38, P1, DOI [10.3760/cma.j.issn.1673-4149.2011.01.001, DOI 10.3760/CMA.J.ISSN.1673-4149.2011.01.001]
  • [4] Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma
    Honda, Masao
    Shirasaki, Takayoshi
    Terashima, Takeshi
    Kawaguchi, Kazunori
    Nakamura, Mikiko
    Oishi, Naoki
    Wang, Xuyang
    Shimakami, Tetsuro
    Okada, Hikari
    Arai, Kuniaki
    Yamashita, Taro
    Sakai, Yoshio
    Yamashita, Tatsuya
    Mizukoshi, Eishiro
    Kaneko, Shuichi
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (07) : 1096 - 1106
  • [5] HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Kobayashi, Masahiro
    Hirakawa, Miharu
    Kawamura, Yusuke
    Yatsuji, Hiromi
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    [J]. LIVER INTERNATIONAL, 2010, 30 (10) : 1461 - 1470
  • [6] Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naive HBV-infected individuals
    Huang, Hongxin
    Wang, Jie
    Li, Weijie
    Chen, Ran
    Chen, Xiangmei
    Zhang, Fengmin
    Xu, Dongping
    Lu, Fengmin
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2018, 99-100 : 71 - 78
  • [7] Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients
    Jung, Kyu Sik
    Park, Jun Yong
    Chon, Young Eun
    Kim, Hyon-Suk
    Kang, Wonseok
    Kim, Beom Kyung
    Kim, Seung Up
    Kim, Do Young
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    [J]. JOURNAL OF GASTROENTEROLOGY, 2016, 51 (08) : 830 - 839
  • [8] Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels
    Lam, Yuk-Fai
    Seto, Wai-Kay
    Wong, Danny
    Cheung, Ka-Shing
    Fung, James
    Mak, Lung-Yi
    Yuen, John
    Chong, Chun-Kong
    Lai, Ching-Lung
    Yuen, Man-Fung
    [J]. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2017, 8
  • [9] Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D
    Maasoumy, B.
    Wiegand, S. B.
    Jaroszewicz, J.
    Bremer, B.
    Lehmann, P.
    Deterding, K.
    Taranta, A.
    Manns, M. P.
    Wedemeyer, H.
    Glebe, D.
    Cornberg, M.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (06) : 606.e1 - 606.e10
  • [10] Low serum level of hepatitis B indicates unlikely reactivation core-related antigen of hepatitis after cessation of lamivudine therapy
    Matsumoto, Akihiro
    Tanaka, Eiji
    Minami, Masahito
    Okanoue, Takeshi
    Yatsuhashi, Hiroshi
    Nagaoka, Shinya
    Suzuki, Fumitaka
    Kobayashi, Mariko
    Chayama, Kazuaki
    Imamura, Michio
    Yotsuyanagi, Hiroshi
    Nakaoka, Shigeru
    Maki, Noboru
    Kawata, Sumio
    Kumada, Hiromitsu
    Iino, Shiro
    Kiyosawa, Kendo
    [J]. HEPATOLOGY RESEARCH, 2007, 37 (08) : 661 - 666